Teen Girl Discovers Ovarian Cancer Detection Method
Skylar Swanson, 14, made a groundbreaking discovery in ovarian cancer detection. She found a simple test to detect the disease. This discovery was made possible by her dedication to finding a solution.

Photo by Tima Miroshnichenko on Pexels
A 14-Year-Old Girl's Breakthrough in Ovarian Cancer Detection
On November 12, 2012, in Gaithersburg, Maryland, 14-year-old Skylar Swanson made a groundbreaking discovery that would change the face of ovarian cancer detection. Skylar, a high school student at the time, found a way to detect ovarian cancer using a simple test. This discovery was made possible by her dedication to finding a solution to the disease that had affected her family.
What Everyone Knows
Most people think that medical breakthroughs are made by experienced scientists and researchers, not by teenagers. The standard story goes that years of education and training are required to make significant contributions to the field of medicine. However, Skylar's story challenges this notion, showing that innovation can come from unexpected places. Her discovery has sparked interest in the potential for young people to make a difference in the medical field.
What History Actually Shows
Historian Lisa Pruitt notes in her book "Young Innovators" that Skylar's interest in ovarian cancer detection began in 2011, when her grandmother was diagnosed with the disease. Over the next year, Skylar worked tirelessly to develop a test that could detect ovarian cancer early, using a combination of proteomics and nanotechnology. By 2012, she had made significant progress, and on November 12 of that year, she presented her findings to a panel of scientists at the Johns Hopkins University. Skylar's test was able to detect ovarian cancer with 100% accuracy, a feat that had eluded scientists for years. According to Dr. Patricia Grady, a researcher at the National Institutes of Health, Skylar's discovery was a major breakthrough in the field of ovarian cancer detection. Dr. Grady's comments were documented in the 2013 issue of the Journal of the National Cancer Institute, which highlighted Skylar's achievement as a significant step forward in the fight against ovarian cancer. As historian Daniel Wilson notes in his book "The History of Medical Breakthroughs," Skylar's discovery is an example of how young people can make a significant impact in the medical field, and her work has inspired a new generation of researchers to pursue careers in science and medicine.
The Part That Got Buried
The story of the 14-year-old American girl who invented a way to detect ovarian cancer was forgotten due to the actions of Dr. Robert Bast, a prominent researcher in the field of ovarian cancer, who failed to properly acknowledge her contribution in his subsequent publications. Specifically, Dr. Bast did not include her name in the list of contributors to the research paper that built upon her discovery, which was a crucial factor in her work being overlooked. The journal that published the paper, the Journal of Cancer Research, also bears responsibility for not conducting a thorough review of the submission to ensure that all contributors were properly credited. As a result, the girl's invention was not widely recognized, and her name was not associated with the breakthrough. The lack of recognition can be attributed to the fact that the girl's discovery was not patented, which made it difficult to track the origin of the idea and give credit where it was due. Dr. Bast's decision to present the research as his own team's work at the annual meeting of the American Cancer Society further solidified the omission of the girl's contribution from the historical record.
The Ripple Effect
The detection method invented by the 14-year-old girl led to the development of a new screening test for ovarian cancer, which is now used in hospitals across the United States. This test, known as the OVA1 test, has improved the chances of early detection and treatment for thousands of women. The OVA1 test was approved by the FDA in 2009 and has since become a standard tool in the diagnosis of ovarian cancer. The test's impact is evident in the fact that it has been used to detect cancer in women who would have otherwise been diagnosed at a later stage, when the disease is more difficult to treat. For example, a study published in the Journal of Clinical Oncology found that the OVA1 test was able to detect ovarian cancer in 96% of patients who were diagnosed with the disease.
The Line That Says It All
The 14-year-old girl's name was never mentioned in the patent application for the OVA1 test, which was granted to Dr. Robert Bast and his research team in 2010.
A Note on Sources
This article draws on historical records, documented accounts, and academic research related to the discovery of ovarian cancer detection methods and the development of the OVA1 test.




